OvaScience Company Profile (NASDAQ:OVAS)

About OvaScience

OvaScience logoOvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's own ovarian tissue. The Company's AUGMENT treatment is designed to improve egg health by supplementing a mitochondrial deficiency. With the AUGMENT treatment, energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs during the in vitro fertilization process to supplement the existing mitochondria. Its OvaPrime treatment is a fertility treatment designed to replenish a woman's ovary by increasing her egg reserve using her own EggPC cells. Its OvaTure treatment is a fertility treatment that seeks to create mature fertilizable eggs in vitro from a woman's own EggPC cells without the need for hormone hyperstimulation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OVAS
  • CUSIP:
Key Metrics:
  • Previous Close: $6.19
  • 50 Day Moving Average: $5.60
  • 200 Day Moving Average: $7.09
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.23
  • P/E Growth: 0.00
  • Market Cap: $220.12M
  • Outstanding Shares: 35,561,000
  • Beta: 4.1
Additional Links:
Companies Related to OvaScience:

Analyst Ratings

Consensus Ratings for OvaScience (NASDAQ:OVAS) (?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $11.64 (88.02% upside)

Analysts' Ratings History for OvaScience (NASDAQ:OVAS)
DateFirmActionRatingPrice TargetDetails
8/10/2016JMP SecuritiesReiterated RatingNeutralView Rating Details
8/5/2016JPMorgan Chase & Co.Lower Price TargetNeutral$9.00 -> $8.00View Rating Details
7/12/2016Credit Suisse Group AGReiterated RatingSellView Rating Details
5/8/2016Leerink SwannReiterated RatingHold$6.00 -> $7.00View Rating Details
4/25/2016Oppenheimer Holdings Inc.Reiterated RatingHoldView Rating Details
3/21/2016S&P Equity ResearchLower Price Target$10.82 -> $8.83View Rating Details
2/17/2016HC WainwrightReiterated RatingBuy$15.00View Rating Details
10/2/2015WedbushLower Price TargetOutperform$46.00 -> $15.00View Rating Details
(Data available from 8/23/2014 forward)


Earnings History for OvaScience (NASDAQ:OVAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.78)($0.62)$0.21 million$0.19 millionViewListenView Earnings Details
5/5/2016Q116($0.72)($0.80)$0.14 million$0.15 millionViewListenView Earnings Details
2/25/2016Q315($0.71)($0.76)$0.27 millionViewListenView Earnings Details
11/5/2015Q3($0.68)($0.66)$0.17 million$0.08 millionViewN/AView Earnings Details
8/10/2015Q215($0.64)($0.64)ViewN/AView Earnings Details
5/11/2015($0.65)($0.65)$0.40 million$0.02 millionViewN/AView Earnings Details
3/16/2015Q414($0.59)($0.79)ViewN/AView Earnings Details
11/10/2014Q314($0.44)($0.54)ViewN/AView Earnings Details
8/7/2014Q214($0.45)($0.42)ViewN/AView Earnings Details
5/8/2014($0.46)($0.41)ViewN/AView Earnings Details
2/27/2014Q413($0.39)($0.64)ViewN/AView Earnings Details
11/13/2013Q313($0.35)($0.40)ViewN/AView Earnings Details
8/13/2013Q213($0.28)($0.36)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for OvaScience (NASDAQ:OVAS)
Current Year EPS Consensus Estimate: $-2.66 EPS
Next Year EPS Consensus Estimate: $-2.78 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.81)($0.81)($0.81)
Q3 20161($0.81)($0.81)($0.81)
Q4 20161($0.70)($0.70)($0.70)
(Data provided by Zacks Investment Research)


Dividend History for OvaScience (NASDAQ:OVAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OvaScience (NASDAQ:OVAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/1/2016Michelle DippCEOBuy425,000$7.00$2,975,000.00View SEC Filing  
5/18/2016Michelle DippCEOBuy20,000$7.86$157,200.00View SEC Filing  
5/17/2016Michelle DippCEOBuy40,000$7.63$305,200.00View SEC Filing  
5/13/2016Richard AldrichDirectorBuy36,095$6.94$250,499.30View SEC Filing  
5/11/2016Richard AldrichDirectorBuy20,000$7.64$152,800.00View SEC Filing  
5/10/2016Michelle DippCEOBuy19,900$7.72$153,628.00View SEC Filing  
5/10/2016Paul W.D. ChapmanCOOBuy3,100$7.37$22,847.00View SEC Filing  
3/24/2016Michelle DippCEOBuy59,800$9.49$567,502.00View SEC Filing  
3/22/2016Michelle DippCEOBuy59,800$10.44$624,312.00View SEC Filing  
3/18/2016Michelle DippCEOBuy59,700$8.26$493,122.00View SEC Filing  
3/16/2016Michelle DippCEOBuy59,029$7.90$466,329.10View SEC Filing  
3/14/2016Michelle DippCEOBuy162,732$7.60$1,236,763.20View SEC Filing  
10/5/2015Jeffrey E YoungCFOBuy3,450$10.70$36,915.00View SEC Filing  
10/5/2015Marc D KozinDirectorBuy4,800$10.79$51,792.00View SEC Filing  
9/9/2015Mary FisherDirectorBuy6,100$16.49$100,589.00View SEC Filing  
9/8/2015Marc D KozinDirectorBuy3,000$17.60$52,800.00View SEC Filing  
4/8/2015Marc D KozinDirectorBuy3,000$28.45$85,350.00View SEC Filing  
4/2/2015Michelle DippCEOBuy1,000$32.49$32,490.00View SEC Filing  
1/13/2015Thomas MalleyDirectorBuy35,000$50.00$1,750,000.00View SEC Filing  
7/7/2014Richard AldrichDirectorBuy2,000$9.49$18,980.00View SEC Filing  
6/30/2014Richard AldrichDirectorBuy2,000$9.16$18,320.00View SEC Filing  
6/23/2014Richard AldrichDirectorBuy2,000$8.81$17,620.00View SEC Filing  
6/16/2014Richard AldrichDirectorBuy2,000$8.52$17,040.00View SEC Filing  
6/9/2014Richard AldrichDirectorBuy2,000$7.59$15,180.00View SEC Filing  
6/3/2014Harald F StockDirectorBuy1,063$7.01$7,451.63View SEC Filing  
6/2/2014Richard AldrichDirectorBuy2,000$7.29$14,580.00View SEC Filing  
5/27/2014Richard AldrichDirectorBuy2,000$7.50$15,000.00View SEC Filing  
5/20/2014Harald F StockDirectorBuy1,050$7.13$7,486.50View SEC Filing  
5/19/2014Richard AldrichDirectorBuy2,000$7.33$14,660.00View SEC Filing  
3/7/2014Fund L.P. LongwoodMajor ShareholderBuy100,000$10.00$1,000,000.00View SEC Filing  
9/12/2013Arthur TzianabosInsiderBuy1,000$10.32$10,320.00View SEC Filing  
9/12/2013Harald F StockDirectorBuy4,500$10.64$47,880.00View SEC Filing  
9/11/2013Christopher A BleckInsiderBuy2,000$11.15$22,300.00View SEC Filing  
9/11/2013Richard AldrichDirectorBuy4,850$10.54$51,119.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for OvaScience (NASDAQ:OVAS)
News IconStock Tracking Lower for the Quarter: OvaScience, Inc. (NASDAQ:OVAS) - Post News (NASDAQ:OVAS)
www.kentuckypostnews.com - August 20 at 6:20 PM
News IconIn vitro Fertilization Devices and Consumables Market Size, Size, Share, Trends, Regional Outlook and Forecast Report 2020 – Acute Market Reports (NASDAQ:OVAS)
www.usfinancialnewstoday.com - August 18 at 6:53 PM
investornewswire.com logoWill Ovascience Inc. (NASDAQ:OVAS) Hit $15 Price Target? - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - August 17 at 6:58 PM
finance.yahoo.com logoEdited Transcript of OVAS earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:OVAS)
finance.yahoo.com - August 15 at 7:01 PM
capitalcube.com logoETF’s with exposure to OvaScience, Inc. : August 15, 2016 (NASDAQ:OVAS)
www.capitalcube.com - August 15 at 7:01 PM
capitalcube.com logoOvaScience, Inc. :OVAS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:OVAS)
www.capitalcube.com - August 12 at 6:50 PM
finance.yahoo.com logoOVASCIENCE, INC. Financials (NASDAQ:OVAS)
finance.yahoo.com - August 12 at 6:50 PM
finance.yahoo.com logoCan The Uptrend Continue for OvaScience (OVAS)? (NASDAQ:OVAS)
finance.yahoo.com - August 11 at 9:56 AM
fortune.com logoAttention Grabbing Analyst Research Reports: OvaScience Inc ... - Review Fortune (NASDAQ:OVAS)
reviewfortune.com - August 9 at 9:55 AM
smarteranalyst.com logoJMP Securities Remains Sidelined on OvaScience Inc (OVAS) Following 2Q:16 Update - Smarter Analyst (NASDAQ:OVAS)
www.smarteranalyst.com - August 8 at 6:57 PM
News IconOvaScience Inc. reports second-quarter earnings (OVAS) - BNB Daily - BNB Daily (blog) (NASDAQ:OVAS)
www.baseball-news-blog.com - August 6 at 6:48 PM
equities.com logoOvaScience Inc. (OVAS) Jumps 13.08% on August 05 - Equities.com (NASDAQ:OVAS)
www.equities.com - August 6 at 9:30 AM
sg.finance.yahoo.com logoOvaScience reports 2Q loss (NASDAQ:OVAS)
sg.finance.yahoo.com - August 4 at 7:08 PM
biz.yahoo.com logoOvaScience Inc Earnings Call (Q2 2016) (NASDAQ:OVAS)
biz.yahoo.com - August 4 at 9:53 AM
biz.yahoo.com logoQ2 2016 OvaScience Inc Earnings Release - After Market Close (NASDAQ:OVAS)
biz.yahoo.com - August 4 at 9:53 AM
investornewswire.com logoEarnings Surprise in Focus: Ovascience Inc. (NASDAQ:OVAS) - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - August 1 at 6:28 PM
equities.com logoOvaScience Inc. (OVAS) Drops 5.66% on July 28 - Equities.com (NASDAQ:OVAS)
www.equities.com - July 29 at 6:51 PM
finance.yahoo.com logoOvaScience to Host Second Quarter 2016 Financial Results Conference Call (NASDAQ:OVAS)
finance.yahoo.com - July 28 at 4:05 PM
investornewswire.com logoCan Shares Of Ovascience Inc. (NASDAQ:OVAS) Hit $15? - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - July 26 at 7:00 PM
kcregister.com logoOvaScience, Inc. (NASDAQ:OVAS) decreased -0.97%: EMC Corporation (NYSE:EMC), Itau Unibanco Holding (NYSE ... - KC Register (NASDAQ:OVAS)
www.kcregister.com - July 25 at 6:53 PM
News IconOvascience Inc. (NASDAQ:OVAS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 23 at 10:37 AM
News IconEquity Roundup: Stock Performance Focus on Ovascience Inc. (NASDAQ:OVAS) - Press Telegraph (NASDAQ:OVAS)
presstelegraph.com - July 20 at 7:29 PM
News IconCould OvaScience Inc Rise Even More? The Stock Had Another Big Increase Today - Consumer Eagle (NASDAQ:OVAS)
www.consumereagle.com - July 20 at 7:29 PM
News IconHeightened Volatility Spotted on Shares of: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 19 at 6:51 PM
investornewswire.com logoIs $15 Price Target Attainable For Ovascience Inc. (NASDAQ:OVAS)? - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - July 19 at 6:51 PM
equities.com logoOvaScience Inc. (OVAS) Jumps 5.14% on July 18 - Equities.com (NASDAQ:OVAS)
www.equities.com - July 19 at 6:51 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Ovascience Inc. (NASDAQ:OVAS) - TGP (NASDAQ:OVAS)
telanaganapress.com - July 19 at 7:41 AM
News IconWere Analysts Bullish OvaScience Inc (NASDAQ:OVAS) This Week? - Consumer Eagle (NASDAQ:OVAS)
www.consumereagle.com - July 18 at 12:06 PM
News IconShares Moving Down on the Week: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 18 at 12:06 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Ovascience Inc. (OVAS) - Fiscal Standard (NASDAQ:OVAS)
www.fiscalstandard.com - July 18 at 12:06 PM
News IconOvascience Inc. (NASDAQ:OVAS) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 15 at 11:45 AM
News IconWhat's Ahead for OvaScience Inc After Today's Huge Decline? - Consumer Eagle (NASDAQ:OVAS)
www.consumereagle.com - July 15 at 11:45 AM
News IconEye on Stock Volatility for: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 14 at 7:00 PM
News IconAnalyst Target and Average Rating Watch: Ovascience Inc. (NASDAQ:OVAS) - Press Telegraph (NASDAQ:OVAS)
presstelegraph.com - July 14 at 7:00 PM
news.cmlviz.com logoOvaScience Inc Realized Volatility Hits Extreme Level - CML News (NASDAQ:OVAS)
news.cmlviz.com - July 14 at 7:00 PM
News IconShare Volatility Watch for: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 13 at 7:02 PM
investornewswire.com logoStrong Sell Calls For Ovascience Inc. (NASDAQ:OVAS) At 0 - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - July 13 at 9:38 AM
news.cmlviz.com logoOption Market: OvaScience Inc Risk Hits An Extreme High - CML News (NASDAQ:OVAS)
news.cmlviz.com - July 13 at 9:38 AM
News IconDo Institutional Investors Hate Ovascience Inc (NASDAQ:OVAS)? - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 10 at 10:50 AM
News IconAre Analysts Bullish OvaScience Inc (NASDAQ:OVAS) After Last Week? - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 9 at 9:53 AM
news.cmlviz.com logoOvaScience, Inc. Stock Momentum Hits Weakness - CML News (NASDAQ:OVAS)
news.cmlviz.com - July 8 at 9:37 AM
einnews.com logoIn- Vitro Fertilization (IVF) Market to Reach $5.66 billion with 20.9% CAGR to 2022 (NASDAQ:OVAS)
www.einnews.com - July 7 at 9:36 AM
News IconShare Performance Recap for: OvaScience, Inc. (NASDAQ:OVAS) - Press Telegraph (NASDAQ:OVAS)
presstelegraph.com - July 6 at 6:54 PM
investornewswire.com logoOvascience Inc. (NASDAQ:OVAS) Expected to Reach Highs Of $15 - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - July 6 at 6:54 PM
equities.com logoOvaScience Inc. (OVAS) Drops 5.73% on July 05 - Equities.com (NASDAQ:OVAS)
www.equities.com - July 6 at 6:54 PM
News IconTracking Stock Volatility for: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily (NASDAQ:OVAS)
www.engelwooddaily.com - July 2 at 9:28 AM
fiscalstandard.com logoRecently Issued Stock Ratings For Ovascience Inc. (OVAS) - Fiscal Standard (NASDAQ:OVAS)
www.fiscalstandard.com - July 1 at 9:27 AM
biz.yahoo.com logoOVASCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:OVAS)
biz.yahoo.com - July 1 at 8:19 AM
finance.yahoo.com logo7:10 am OvaScience announces Dr. Harald Stock has officially succeeded co-founder Michelle Dipp as CEO, completing the planned leadership transition from CEO-elect (NASDAQ:OVAS)
finance.yahoo.com - July 1 at 7:10 AM
finance.yahoo.com logoHarald Stock, Ph.D. Commences Role as President and Chief Executive Officer of OvaScience (NASDAQ:OVAS)
finance.yahoo.com - July 1 at 7:00 AM


OvaScience (NASDAQ:OVAS) Chart for Tuesday, August, 23, 2016

Last Updated on 8/23/2016 by MarketBeat.com Staff